CClinicalTrials.gg
CompletedNCT05196776Updated Nov 1, 2023Results posted

Diagnostic Accuracy of Handheld vs Traditional Ultrasound

An interventional study of Portable, handheld point-of-care ultrasound device and Cart-based point-of-care ultrasound device in Image, Body, sponsored by Temple University. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-11-01.

Sponsored by Temple University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Patients receiving a point-of-care ultrasound will be randomized into a portable, handheld device or a traditional cart-based ultrasound machine to compare diagnostic capability.

Read the detailed description

Patients who require a point-of-care ultrasound examination of their kidneys, gallbladder, heart, lung, or aorta will be enrolled. Once enrolled, the patient will be randomized to receive the point-of-care ultrasound using a portable, handheld ultrasound or a traditional cart based model. The ultrasound examinations will be performed by emergency medicine post-graduate year 1-3 residents or an ultrasound fellow and reviewed by the supervising emergency medicine attending physicians credentialed in performing and interpreting point-of-care ultrasound.

Based on the clinical presentation, the provider will perform one of the following ultrasounds: cardiac to assess ejection fraction ( \<50%, 30-50%, \<30%), lung to assess for presence or absence of B-lines, gallbladder to assess for the presence or absence of gallstones, renal to assess for the presence or absence of hydronephrosis, or aorta to assess for the presence or absence of an aneurysm. The diagnostic accuracy of the portable, handheld and the cart-based model will be assessed using the following as the diagnostic standard: cardiology-interpreted echocardiogram, radiology-interpreted ultrasound or computed tomography, or quality review of the point-of-care ultrasound by 3 ultrasound fellowship trained physicians.

02

Conditions studied

  • Image, Body
03

In context

Lead sponsor

Temple University is the lead sponsor of 219 studies on the registry; 30 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 7 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. English and Spanish-speaking patients, who require a gallbladder, cardiac, renal, aorta, or lung ultrasound based on the discretion of the treating physician.

Exclusion criteria

Exclusion Criteria:

  1. All other non-English and non-Spanish speaking patients
  2. Vulnerable groups
  3. Patients unable to consent
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
110 participants (actual)

Study arms

  • Experimental
    Portable, Handheld Device

    Patients will receive a point-of-care ultrasound using a handheld, portable ultrasound device.

    Device: Portable, handheld point-of-care ultrasound device

  • Active comparator
    Traditional, Cart-based Ultrasound

    Patients will receive a point-of-care ultrasound using a traditional, cart-based ultrasound machine.

    Device: Cart-based point-of-care ultrasound device

Interventions

  • DevicePortable, handheld point-of-care ultrasound device

    The patient will have an ultrasound performed using a handheld, portable device.

  • DeviceCart-based point-of-care ultrasound device

    The patient will have an ultrasound performed using a traditional cart-based model.

06

What researchers measure

Primary outcomes

  1. Diagnostic Accuracy

    The primary outcome will be difference in diagnostic accuracy between the two methods (the percent of diagnostic accuracy of the hand-held and the percent of diagnostic accuracy of the cart-based model).

    Time frame: 1 day

Secondary outcomes

  1. Image Quality by Expert Review

    Using a Likert scale of 1-7 (1 = unable to assess image; 7 = highest quality), ultrasound fellowship-trained providers will assess the image quality of images obtained by each provide in the study.

    Time frame: 1 day

07

Results

Posted Nov 1, 2023

Participant flow

Participant flow — Overall Study
MilestonePortable, Handheld DeviceTraditional, Cart-based Ultrasound
Started5456
Completed5356
Not completed10

Outcome measures

PrimaryDiagnostic Accuracy

The primary outcome will be difference in diagnostic accuracy between the two methods (the percent of diagnostic accuracy of the hand-held and the percent of diagnostic accuracy of the cart-based model).

Time frame:
1 day
Reported as:
Count of participants · Participants
Diagnostic Accuracy
ParticipantsPortable, Handheld DeviceTraditional, Cart-based Ultrasound
Diagnostic Accuracy5356
SecondaryImage Quality by Expert Review

Using a Likert scale of 1-7 (1 = unable to assess image; 7 = highest quality), ultrasound fellowship-trained providers will assess the image quality of images obtained by each provide in the study.

Time frame:
1 day
Reported as:
Median · score on a scale
Image Quality by Expert Review
score on a scalePortable, Handheld DeviceTraditional, Cart-based Ultrasound
Image Quality by Expert Review4 (1 to 7)5 (1 to 7)

Adverse events

Collected over 1 day. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Portable, Handheld Device0/54 (0%)0/54 (0%)0/54 (0%)
Traditional, Cart-based Ultrasound0/56 (0%)0/56 (0%)0/56 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Portable, Handheld DeviceTraditional, Cart-based UltrasoundTotal
Median60 (18 to 89)57 (18 to 90)59 (18 to 90)
Sex: Female, Male
Sex: Female, Male(Participants)Portable, Handheld DeviceTraditional, Cart-based UltrasoundTotal
Female273461
Male262248
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Portable, Handheld DeviceTraditional, Cart-based UltrasoundTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(Participants)Portable, Handheld DeviceTraditional, Cart-based UltrasoundTotal
United States5356109
08

Study locations

1 site
  • Lewis Katz School of Medicine at Temple University
    Philadelphia, Pennsylvania 19140, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 2, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05196776
Lead sponsor
Temple University
Responsible party
Sponsor
First posted
Jan 19, 2022
Start date
Oct 1, 2021
Primary completion
Mar 1, 2022
Completion
Mar 1, 2022
Results posted
Nov 1, 2023
Last update
Nov 1, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion